Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov-Dec;23(21-24):931-948.
doi: 10.1080/15384101.2025.2484868. Epub 2025 Mar 27.

Non-canonical functions of BCL-2 family members in energy metabolism and necrotic cell death regulation

Affiliations
Review

Non-canonical functions of BCL-2 family members in energy metabolism and necrotic cell death regulation

Mohamed El-Mesery et al. Cell Cycle. 2024 Nov-Dec.

Abstract

The large family of BCL-2 proteins plays a well-established role in the regulation of mitochondrial apoptosis pathway, and the crosstalk between death receptor signaling and mitochondrial apoptosis. Accumulating evidence suggests, however, that various BCL-2 family members are also involved in the regulation of apoptosis-unrelated necrotic forms of cell death, and even non-cell death processes. In this review, we discuss the emerging role of BCL-2 family members, and in particular BIM, in the regulation of mitochondrial dynamics, morphology and energy metabolism, and associated consequences for drug-inuced necrotic cell death.

Keywords: BCL-2; apoptosis; electron transport chain; glycolysis; mitochondria; mitotoxicants.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Canonical functions of the BCL-2 family. The canonical BCL-2 protein function, i.e. apoptosis, is triggered by extracellular and/or intracellular stimuli, which disturb the balance between pro- and anti-apoptotic BCL-2 proteins. Extracellular stimuli start with death receptor activation (such as TNF-R1, FAS and TRAIL-Rs), leading to DISC assembly and caspase 8 activation. Activated caspase 8 either directly activates the effector caspases 3 and 7, or triggers the intrinsic apoptosis pathway by inducing BID cleavage and the release of truncated BID (tBID). Intracellular stress stimuli affect the balance between BCL-2 proteins by transcriptional induction or posttranslational activation of BCL-2 proteins. There are two modes how the pore-forming members BAX and BAK become activated, the direct and indirect way. In the indirect way, anti-apoptotic proteins are neutralized by activated or overexpressed BH3-only proteins, which triggers BAX/BAK oligomerization and MOMP induction. The direct mode requires direct activation of BAX/BAK by certain BH3-only proteins to induce MOMP, which is antagonized by anti-apoptotic BCL-2 proteins. MOMP induction leads to the release of different mitochondrial proteins into the cytoplasm, such as cytochrome c and SMAC/DIABLO. Cytochrome c release induces apoptosome assembly, which triggers caspase 9 activation, subsequent activation of the effector caspases 3 and 7, and apoptosis induction.
Figure 2.
Figure 2.
Non-canonical functions of BCL-2 homologs in mitochondrial metabolism and morphology. (a). In addition to their canonical functions, BCL-2 proteins excert non-canonical functions at the mitochondrial cristae by regulating mitochondrial respiration through interaction with complexes of the electron transport chain (ETC). Anti-apoptotic BCL-2 homologs positively regulate the ETC, via interaction with complex IV (cIV), complex V (cV) or by promoting the formation of supercomplexes (cIII2cIV, cIcIII2cIV). The pore-forming BCL-2 protein BAX is a negative regulator of the ETC by inhibiting complex I (cI). (b). BCL-2 proteins regulate mitochondrial morphology and function through fission and fusion. BID and BIM can inhibit DRP1 oligomerization-mediated fission, while BCL-xL can enhance it. BAX and BAK interact with MFN2 and promote mitochondrial fusion. Yet to be confirmed is the exact molecular role of interactions of BCL-2 proteins with regulators of mitochondrial morphology, such as that of MCL-1 with DRP1 and OPA1, or BCL-2 and BCL-xL with MFN2. The role of BID and BIM in mitochondrial fusion processes remains unknown.
Figure 3.
Figure 3.
Summary of canonical and non-canonical functions of BCL-2 homologs. Cellular functions of BCL-2 proteins are divided into canonical and non-canonical functions. Canonical functions are related to MOMP induction and subsequent execution of apoptotic cell death, which is considered immunologically silent. Non-canonical functions include the role of BCL-2 proteins in energy metabolism, regulation of mitochondrial fission/fusion and ROS production. Mitotoxicants damage the mitochondria, inhibit the ETC, promote ROS production and induce expression of BH3-only proteins. BCL-2 family members regulate mitochondrial energy metabolism and fission/fusion. Since the apoptosome activation requires ATP, and ROS inhibits caspase activation, BCL-2 family members also regulate necrotic cell death and associated inflammation.

References

    1. Vega F, Medeiros LJ.. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med. 2003. Sep;127(9):1148–1160. doi: 10.5858/2003-127-1148-CTIINL - DOI - PubMed
    1. Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023. Feb;28(1–2):20–38. doi: 10.1007/s10495-022-01780-7 - DOI - PMC - PubMed
    1. Thomas S, Quinn BA, Das SK, et al. Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets. 2013. Jan;17(1):61–75. doi: 10.1517/14728222.2013.733001 - DOI - PMC - PubMed
    1. Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014. Jan;15(1):49–63. doi: 10.1038/nrm3722 - DOI - PubMed
    1. Hatok J, Racay P. Bcl-2 family proteins: master regulators of cell survival. Biomol Concepts. 2016. Aug 1;7(4):259–270. doi: 10.1515/bmc-2016-0015 - DOI - PubMed

Substances

LinkOut - more resources